Impact of 68Ga-FAPi PET/CT on Staging or Restaging Digestive System Tumors in Patients with Negative or Equivocal 18F-FDG PET/CT Findings
Based on our study, <sup>68</sup>Ga-FAPi PET/CT alters the disease stage in the majority of gastrointestinal malignancies with negative or equivocal <sup>18</sup>F-FDG PET/CT findings. <sup>68</sup>Ga-FAPi PET/CT appears to be effective in both staging and restaging of gastrointestinal malignancies, such as signet-ring cell carcinomas of the stomach that frequently show low <sup>18</sup>F-FDG -avidity.
Authors
- Emre Demirci (ORCID: https://orcid.org/0000-0002-6387-9089)
- Levent Kabasakal (ORCID: https://orcid.org/0000-0002-4050-1972)
- Ayşegül Görmez (ORCID: https://orcid.org/0000-0001-5620-2881)
- Nalan Alan Selçuk (ORCID: https://orcid.org/0000-0002-3738-6491)
- Bala Başak Öven Ustaalıoğlu (ORCID: https://orcid.org/0000-0002-9921-4089)
- Kaan Akçay (ORCID: https://orcid.org/0000-0002-7706-6388)
- Gamze Beydağı (ORCID: https://orcid.org/0000-0001-7187-7203)
- Özge Kapar (ORCID: https://orcid.org/0000-0001-6751-758X)
- Serkan Çelik (ORCID: https://orcid.org/0000-0002-5124-6823)
- Fatma Şen (ORCID: https://orcid.org/0009-0003-9026-886X)
Institutions
- Yeditepe University (TR)
- Avrasya University (TR)
- Istanbul University-Cerrahpaşa (TR)
- İstanbul Kanuni Sultan Süleyman Eğitim ve Araştırma Hastanesi (TR)
- University of Missouri (US)
Publication Details
- Journal
- Molecular Imaging and Radionuclide Therapy
- Published
- 2025-02-07
- DOI
- https://doi.org/10.4274/mirt.galenos.2024.50470
- Citations
- 5
- Primary Topic
- Peptidase Inhibition and Analysis
- Type
- article
- Field-Weighted Citation Impact
- 5.23